AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18438806 — intervention group
Group type: COMPARATOR
Intervention: Control group (hospitalists working independently)
Number of subjects: 693
Study 16929704 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NFB) training
Number of subjects: 0
Study 16929704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12769148 — intervention group
Group type: EXPERIMENTAL
Intervention: Menicon Z rigid gas‐permeable (RGP) contact lenses
Number of subjects: 60
Study 12769148 — intervention group
Group type: COMPARATOR
Intervention: ACUVUE hydrogel lenses
Number of subjects: 60
Study 10694106 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretch group (20-s static stretch for each of six major leg muscle groups during warm-up)
Number of subjects: 1538
Study 10694106 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stretching)
Number of subjects: 1538
Study 10694106 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (preexercise stretching effect)
Number of subjects: 1538
Study 9062091 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.2 microgram per kilogram of body weight per minute)
Number of subjects: 504
Study 9062091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 504
Study 8446441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fenfluramine (60 mg)/morphine infusion
Number of subjects: 10
Study 8446441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fenfluramine (60 mg)/saline infusion
Number of subjects: 10
Study 8446441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral placebo/morphine infusion
Number of subjects: 10
Study 8446441 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo/saline infusion
Number of subjects: 10
Study 3947405 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative radiologic techniques for assessing joint destruction
Number of subjects: 0
Study 3947405 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended techniques for radiologic assessment
Number of subjects: 0
Study 3947405 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of multiple readers with varying experience levels
Number of subjects: 0
Study 3947405 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading films in pairs
Number of subjects: 0
Study 3947405 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluating 34 joints versus 18 joints
Number of subjects: 0
Study 28885296 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically Assisted Instrument (MAI) applied to C5 of the spine, maximum setting, duration not specified.
Number of subjects: 125
Study 28885296 — intervention group
Group type: COMPARATOR
Intervention: Placebo (MAI turned off), duration not specified.
Number of subjects: 125
Study 26226096 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic antireflux surgery (LARS)
Number of subjects: 267
Study 26226096 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole (20 or 40 mg/d)
Number of subjects: 267
Study 23562749 — intervention group
Group type: COMPARATOR
Intervention: Heavy training (2 weeks)
Number of subjects: 17
Study 23562749 — intervention group
Group type: EXPERIMENTAL
Intervention: Light training (2 weeks)
Number of subjects: 17
Study 23562749 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate recovery
Number of subjects: 17
Study 22627597 — intervention group
Group type: EXPERIMENTAL
Intervention: 80-kVp protocol with a 40% reduction in contrast agent dose and hybrid iterative reconstruction algorithm
Number of subjects: 74
Study 22627597 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid iterative reconstruction
Number of subjects: 74
Study 22627597 — intervention group
Group type: COMPARATOR
Intervention: 80-kVp with iterative reconstruction
Number of subjects: 74
Study 20022087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical instillation of 40 mg hyaluronic acid (HA) weekly for the first month, then monthly for 2 months.
Number of subjects: 47
Study 20022087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical heparin treatment.
Number of subjects: 47
Study 20022087 — intervention group
Group type: COMPARATOR
Intervention: Hydrodistention alone (control group).
Number of subjects: 47
Study 17764888 — intervention group
Group type: EXPERIMENTAL
Intervention: SLN biopsy associated with ALND (ALND arm)
Number of subjects: 697
Study 17764888 — intervention group
Group type: COMPARATOR
Intervention: SLN biopsy followed by ALND only if SLN was metastatic (SLN arm)
Number of subjects: 697
Study 16859191 — intervention group
Group type: COMPARATOR
Intervention: Pyridoxine treatment
Number of subjects: 0
Study 12492665 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide in 30% oxygen
Number of subjects: 18
Study 12492665 — intervention group
Group type: COMPARATOR
Intervention: Air/nitrous oxide/air
Number of subjects: 18
Study 12492665 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide/air/nitrous oxide
Number of subjects: 18
Study 10801243 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir sulfate 800 mg every 8 hours with placebo
Number of subjects: 12
Study 10801243 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg every 12 hours with placebo
Number of subjects: 12
Study 10801243 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir sulfate with clarithromycin
Number of subjects: 12
Study 8632119 — intervention group
Group type: EXPERIMENTAL
Intervention: Whipple procedure
Number of subjects: 24
Study 8632119 — intervention group
Group type: COMPARATOR
Intervention: Control group (post-cholecystectomy)
Number of subjects: 24
Study 1484193 — intervention group
Group type: EXPERIMENTAL
Intervention: High-viscosity suppository formulation
Number of subjects: 14
Study 1484193 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-viscosity suppository formulation
Number of subjects: 14
Study 1484193 — intervention group
Group type: COMPARATOR
Intervention: Oral controlled-release morphine sulfate tablets
Number of subjects: 14
Study 3833089 — intervention group
Group type: EXPERIMENTAL
Intervention: Randt Memory Test (RMT) - five different parallel forms
Number of subjects: 20
Study 30829658 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociception level-guided analgesia
Number of subjects: 80
Study 30829658 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study 28459397 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed tracheal suction group
Number of subjects: 318
Study 28459397 — intervention group
Group type: EXPERIMENTAL
Intervention: Splash-proof suction group
Number of subjects: 318
Study 28459397 — intervention group
Group type: COMPARATOR
Intervention: Open tracheal suction group
Number of subjects: 318
Study 28459397 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 318
Study 26372883 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 496
Study 26372883 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass surgery (CABG)
Number of subjects: 496
Study 25675612 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft toothbrush
Number of subjects: 15
Study 25675612 — intervention group
Group type: COMPARATOR
Intervention: Brushless tooth cleaner
Number of subjects: 15
Study 22664645 — intervention group
Group type: EXPERIMENTAL
Intervention: FACE intervention
Number of subjects: 130
Study 22664645 — intervention group
Group type: COMPARATOR
Intervention: Healthy Living Control
Number of subjects: 130
Study 19064965 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (at least two cycles)
Number of subjects: 117
Study 17312085 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate supplementation plus resistance training (CRE)
Number of subjects: 20
Study 17312085 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose monohydrate) plus resistance training (PLA)
Number of subjects: 20
Study 15458276 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil group (n-3 fatty acids supplement)
Number of subjects: 60
Study 15458276 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 60
Study 15458276 — intervention group
Group type: COMPARATOR
Intervention: Control group (no special diet or intervention)
Number of subjects: 60
Study 11340105 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral exposure to butter
Number of subjects: 17
Study 11340105 — intervention group
Group type: COMPARATOR
Intervention: Fat replacers
Number of subjects: 17
Study 11340105 — intervention group
Group type: COMPARATOR
Intervention: No oral stimulation
Number of subjects: 17
Study 11340105 — intervention group
Group type: COMPARATOR
Intervention: Potatoes
Number of subjects: 17
Study 11340105 — intervention group
Group type: COMPARATOR
Intervention: Potatoes containing butter
Number of subjects: 17
Study 9683309 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin therapy (0.625 mg conjugated estrogens plus 2.5 mg medroxyprogesterone acetate daily)
Number of subjects: 2763
Study 9683309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2763
Study 7831623 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide 500 mg
Number of subjects: 10
Study 7831623 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 7.5 mg
Number of subjects: 10
Study 7831623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3262097 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g acetazolamide (ACZ)
Number of subjects: 15
Study 3262097 — intervention group
Group type: COMPARATOR
Intervention: Control (pre-ACZ study)
Number of subjects: 15
Study 31340842 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB booster dose
Number of subjects: 113
Study 31340842 — intervention group
Group type: COMPARATOR
Intervention: 4CMenB two doses (0 and 28 days or 0 and 365 days)
Number of subjects: 113
Study 31340842 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB doses
Number of subjects: 113
Study 27316706 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine 500 mg/day for 6 months
Number of subjects: 102
Study 27316706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 27999775 — intervention group
Group type: EXPERIMENTAL
Intervention: High tidal volume (HVT) 10 mL/kg of predicted body weight (PBW)
Number of subjects: 60
Study 27999775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume (LVT) 6 mL/kg PBW
Number of subjects: 60
Study 27999775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume combined with moderate hypercapnia (LVT + HC) 6 mL/kg PBW, PaCO2 45-60 mm Hg
Number of subjects: 60
Study 24731535 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary care plus laparoscopic adjustable gastric band surgery
Number of subjects: 51
Study 24731535 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary care only
Number of subjects: 51
Study 22808053 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard walking program (30 minutes/day)
Number of subjects: 16
Study 22808053 — intervention group
Group type: EXPERIMENTAL
Intervention: High walking program (60 minutes/day)
Number of subjects: 16
Study 19407724 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (mean endpoint dose: 2,044.1±1,065.2 mg/day, range: 250-3,000 mg/day)
Number of subjects: 17
Study 19407724 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 17
Study 17463215 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone and 4 mg glimepiride (coadministered)
Number of subjects: 37
Study 17463215 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone and 4 mg glimepiride (fixed-dose combination)
Number of subjects: 37
Study 17463215 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose combination vs coadministered
Number of subjects: 37
Study 17463215 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender analysis
Number of subjects: 37
Study 15094153 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program
Number of subjects: 0
Study 15094153 — intervention group
Group type: COMPARATOR
Intervention: Healthy elderly
Number of subjects: 0
Study 11876711 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy (omeprazole 20 mg b.d., clarithromycin 250 mg b.d., tinidazole 500 mg b.d. for 7 days)
Number of subjects: 2329
Study 11876711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2329
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical resection (> 90%)
Number of subjects: 131
Study 9647172 — intervention group
Group type: COMPARATOR
Intervention: Less extensive resection (<= 90%)
Number of subjects: 131
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical resection (> 90%) for anaplastic astrocytoma
Number of subjects: 131
Study 9647172 — intervention group
Group type: COMPARATOR
Intervention: Less extensive resection (<= 90%) for anaplastic astrocytoma
Number of subjects: 131
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical resection (> 90%) for glioblastoma multiforme
Number of subjects: 131
Study 9647172 — intervention group
Group type: COMPARATOR
Intervention: Less extensive resection (<= 90%) for glioblastoma multiforme
Number of subjects: 131
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement in preoperative neurological deficits
Number of subjects: 131
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement in level of consciousness
Number of subjects: 131
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: New or increased neurological deficits
Number of subjects: 131
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Diminished sensorium after surgery
Number of subjects: 131
Study 9647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative nonneurological complications (infection, hematoma, CSF fistula)
Number of subjects: 131
Study 9031268 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training (30 min of bicycling daily or an equal amount of other physical activities)
Number of subjects: 30
Study 9031268 — intervention group
Group type: COMPARATOR
Intervention: Maintenance of the usual lifestyle
Number of subjects: 30
Study 9031268 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 30
Study 9031268 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 30
Study 1646442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention not specified; only one study suggested an effect on repetition frequency of suicide attempts.
Number of subjects: 0
Study 1646442 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; only one study suggested an effect on repetition frequency of suicide attempts.
Number of subjects: 0
Study 7346693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 160
Study 7346693 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 160
Study 7346693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole plus Aspirin
Number of subjects: 160
Study 7346693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 30768132 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled perch (CP)
Number of subjects: 36
Study 28807037 — intervention group
Group type: EXPERIMENTAL
Intervention: Selepressin 2.5 ng/kg/minute
Number of subjects: 53
Study 28807037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 25037960 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron (0.075 mg IV)
Number of subjects: 152
Study 25037960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 25804372 — intervention group
Group type: COMPARATOR
Intervention: Intact group (no ligament injury)
Number of subjects: 40
Study 25804372 — intervention group
Group type: EXPERIMENTAL
Intervention: Injured group (with SL and/or LT injury)
Number of subjects: 40
Study 25804372 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (comparison)
Number of subjects: 40
Study 23399688 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower numeracy
Number of subjects: 150
Study 23399688 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted analyses
Number of subjects: 150
Study 23399688 — intervention group
Group type: EXPERIMENTAL
Intervention: Numeracy
Number of subjects: 150
Study 23399688 — intervention group
Group type: EXPERIMENTAL
Intervention: Low numeracy
Number of subjects: 150
Study 21280190 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus qd (once-daily formulation)
Number of subjects: 129
Study 21280190 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus bid (twice-daily formulation)
Number of subjects: 129
Study 21280190 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 129
Study 20058595 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum proteomics profiling using SELDI‐TOF MS
Number of subjects: 56
Study 20058595 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein peaks M4168.94 and M1122.57
Number of subjects: 56
Study 17013435 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy (OT)
Number of subjects: 31
Study 17013435 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study 14641441 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch & Prime 3.0
Number of subjects: 60
Study 14641441 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 60
Study 14641441 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt L‐Pop
Number of subjects: 60
Study 14641441 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia F
Number of subjects: 60
Study 14641441 — intervention group
Group type: EXPERIMENTAL
Intervention: Optibond Plus
Number of subjects: 60
Study 14641441 — intervention group
Group type: EXPERIMENTAL
Intervention: Admira Bond
Number of subjects: 60
Study 11049783 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine
Number of subjects: 374
Study 11049783 — intervention group
Group type: COMPARATOR
Intervention: 0.5% tincture of chlorhexidine
Number of subjects: 374
Study 9805329 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive skill learning intervention with immediate feedback
Number of subjects: 26
Study 9805329 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive skill learning intervention with additional trials and immediate feedback
Number of subjects: 26
Study 9805329 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal participants)
Number of subjects: 26
Study 8031477 — intervention group
Group type: EXPERIMENTAL
Intervention: Active prebrushing dental rinse (Advanced Formula Plax)
Number of subjects: 153
Study 8031477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 2510968 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless Steel Ring (SS)
Number of subjects: 96
Study 2510968 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper T220 (TCu)
Number of subjects: 96
Study 2510968 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing IUD (LNG)
Number of subjects: 96
Study 2510968 — intervention group
Group type: COMPARATOR
Intervention: Control (before exposure)
Number of subjects: 96
Study 16749 — intervention group
Group type: EXPERIMENTAL
Intervention: Each of the 5 antacids
Number of subjects: 25
Study 29979488 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-light flexible cystoscopy (BLFC) with hexaminolevulinate
Number of subjects: 304
Study 28667510 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganaxolone (200, 400, and 600 mg twice daily for 6 weeks)
Number of subjects: 112
Study 28667510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 25649275 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo treatment session with inert aqueous cream
Number of subjects: 48
Study 25649275 — intervention group
Group type: COMPARATOR
Intervention: Control session with inert aqueous cream
Number of subjects: 48
Study 23841808 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.83 M concentration of sucrose in water
Number of subjects: 16
Study 23841808 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 16
Study 23841808 — intervention group
Group type: EXPERIMENTAL
Intervention: Rated sucrose liking
Number of subjects: 16
Study 21371717 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy (amoxicillin and omeprazole for 5 days followed by clarithromycin, tinidazole, and omeprazole for 5 days)
Number of subjects: 107
Study 21371717 — intervention group
Group type: COMPARATOR
Intervention: Standard triple therapy (amoxicillin and clarithromycin plus omeprazole for 7 days followed by placebo for 3 days)
Number of subjects: 107
Study 19593017 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based education
Number of subjects: 0
Study 19593017 — intervention group
Group type: COMPARATOR
Intervention: Face to face education with a nurse
Number of subjects: 0
Study 16813788 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized hydraulic knee (Otto Bock C‐leg)
Number of subjects: 8
Study 16813788 — intervention group
Group type: COMPARATOR
Intervention: Noncomputerized hydraulic knee (Ossur Mauch SNS)
Number of subjects: 8
Study 12865832 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 115
Study 12865832 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 115
Study 12865832 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 115
Study 10936666 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 204
Study 10936666 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with longer duration of diabetes
Number of subjects: 204
Study 10936666 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients on insulin treatment
Number of subjects: 204
Study 9595578 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac 1.2 mg/kg every six hrs (Protocol A)
Number of subjects: 52
Study 9595578 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 1.2 mg/kg (bolus) + 0.21 mg/kg/hr (Protocol B)
Number of subjects: 52
Study 9595578 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 1 gamma/kg/hr (Protocol C)
Number of subjects: 52
Study 9595578 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1 gamma/kg/hr + Ketorolac 0.21 mg/kg/hr (Protocol D)
Number of subjects: 52